Several confounding factors linked to inflammation and fibrosis in other organs, such as female sex, age or renal function, mostly influence Galectin-3 levels [31,32]; impaired renal function is common in patients with cardiovascular disease [33], which may underlie the prognostic value of Galectin-3 in CHF. This evidence concerns the gene LGALS3 and cardiovascular disorder.